• Home
  • Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 2: Checkpoint Inhibitors, Immunotherapy Combinations, Tumor Microenvironment Modulation, and Cellular Therapies.

Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 2: Checkpoint Inhibitors, Immunotherapy Combinations, Tumor Microenvironment Modulation, and Cellular Therapies.

Author List
Patel A, Fong L
Publication
Oncology (Williston Park, N.Y.)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/17492837
Publication Year
2018
PubMed ID
29940064
Publication Title
Patel A, Fong L. Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 2: Checkpoint Inhibitors, Immunotherapy Combinations, Tumor Microenvironment Modulation, and Cellular Therapies. Oncology (Williston Park). 2018 06; 32(6):e65-e73.